(Q34373385)

1 August 2017

title

Benzodiazepines: risks and benefits. A reconsideration (English)

1 reference

1 August 2017

7

David J Nutt

0 references

Katherine J. Aitchison

object named as

Katherine Aitchison

2

0 references

Simon J.C. Davies

object named as

Simon Davies

5

0 references

author name string

David S Baldwin

1

1 reference

1 August 2017

Alan Bateson

3

1 reference

1 August 2017

H Valerie Curran

4

1 reference

1 August 2017

Brian Leonard

6

1 reference

1 August 2017

David N Stephens

8

1 reference

1 August 2017

Sue Wilson

9

1 reference

1 August 2017

language of work or name

English

0 references

publication date

24 September 2013

1 reference

Journal of Psychopharmacology

1 August 2017

published in

1 reference

1 August 2017

volume

27

1 reference

1 August 2017

issue

11

1 reference

1 August 2017

page(s)

967-971

1 reference

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881113503509

Substitution therapy for alcoholism: time for a reappraisal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113503509

Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113503509

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113503509

British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113503509

21 January 2018

Identifiers

DOI

10.1177/0269881113503509

1 reference

1 August 2017

1 reference